Over the last 12 months, Maze Therapeutics insiders reported no purchases and 12 sales totaling $4.4M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 34,501 | $26.73 | $922K | -11.9% | plan · 4 tranches · indirect |
| Jul 29, 2026 | Dandekar AtulCSBO · O | ▼ Sale | 7,500 | $27.34 | $205K | -22.2% | plan · 2 tranches |
| Jul 1, 2026 | Bernstein HaroldPresident, R&D & CMO · O | ▼ Sale | 14,609 | $29.9 | $437K | -100% | plan · 2 tranches |
| Jul 1, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 34,501 | $29.98 | $1.0M | -10.7% | plan · 3 tranches · indirect |
| Jun 29, 2026 | Dandekar AtulCSBO · O | ▼ Sale | 7,500 | $28.02 | $210K | -22.2% | plan |
| Jun 23, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 27,858 | $26.04 | $725K | -8% | plan · 3 tranches · indirect |
| Jun 1, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 553 | $26.24 | $15K | -1.9% | plan · indirect |
| Jun 1, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 6,090 | $26.2 | $160K | -1.7% | plan · indirect |
| Jun 1, 2026 | Bernstein HaroldPresident, R&D & CMO · O | ▼ Sale | 1,600 | $26.36 | $42K | -100% | plan |
| Jun 1, 2026 | Bernstein HaroldPresident, R&D & CMO · O | ▼ Sale | 13,253 | $25.57 | $339K | -89.2% | plan |
| May 29, 2026 | Dandekar AtulCSBO · O | ▼ Sale | 7,500 | $26.34 | $198K | -23.2% | plan |
| May 22, 2026 | Coloma Jason VChief Executive Officer · O·D | ▼ Sale | 4,504 | $26 | $117K | -1.2% | plan · indirect |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MAZE feed.